Liposomal drug carrier systems in cancer chemotherapy: Current status and future prospects

被引：45

作者：

Gabizon, AA ^{[1
]}

机构：

[1] Shaare Zedek Med Ctr, Inst Oncol, Jerusalem, Israel

[2] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel

来源：

JOURNAL OF DRUG TARGETING | 2002年 / 10卷 / 07期

关键词：

D O I：

10.1080/1061186021000043061

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：535 / 538

页数：4

共 26 条

[1] Molecular vehicles for targeted drug delivery [J].

Backer, MV ;

Aloise, R ;

Przekop, K ;

Stoletov, K ;

Backer, JM .

BIOCONJUGATE CHEMISTRY, 2002, 13 (03) :462-467

[2] Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models [J].

Bandak, S ;

Goren, D ;

Horowitz, A ;

Tzemach, D ;

Gabizon, A .

ANTI-CANCER DRUGS, 1999, 10 (10) :911-920

[3]

Colbern GT, 1998, CLIN CANCER RES, V4, P3077

[4] Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models [J].

Gabizon, A ;

Tzemach, D ;

Mak, L ;

Bronstein, M ;

Horowitz, AT .

JOURNAL OF DRUG TARGETING, 2002, 10 (07) :539-548

[5] Polyethylene glycol coated (pegylated) liposomal doxorubicin - Rationale for use in solid tumours [J].

Gabizon, A ;

Martin, F .

DRUGS, 1997, 54 (Suppl 4) :15-21

[6] Pegylated liposomal doxorubicin: Metamorphosis of an old drug into a new form of chemotherapy [J].

Gabizon, AA .

CANCER INVESTIGATION, 2001, 19 (04) :424-436

[7] Phase I study of liposomal vincristine [J].

Gelmon, KA ;

Tolcher, A ;

Diab, AR ;

Bally, MB ;

Embree, L ;

Hudon, N ;

Dedhar, C ;

Ayers, D ;

Eisen, A ;

Melosky, B ;

Burge, C ;

Logan, P ;

Mayer, LD .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) :697-705

[8] Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma [J].

Gill, PS ;

Wernz, J ;

Scadden, DT ;

Cohen, P ;

Mukwaya, GM ;

vonRoenn, JH ;

Jacobs, M ;

Kempin, S ;

Silverberg, I ;

Gonzales, G ;

Rarick, MU ;

Myers, AM ;

Shepherd, F ;

Sawka, C ;

Pike, MC ;

Ross, ME .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (08) :2353-2364

[9] Recurrent epithelial ovarian carcinoma: A randomized phase III study of pegylated liposomal doxorubicin versus topotecan [J].

Gordon, AN ;

Fleagle, JT ;

Guthrie, D ;

Parkin, DE ;

Gore, ME ;

Lacave, AJ .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (14) :3312-3322

[10]

Goren D, 2000, CLIN CANCER RES, V6, P1949

← 1 2 3 →